Screener
Agios Pharmaceuticals AGIO EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 51,547 | 45,869 | 99,851 | 87,396 |
| Total operating expenses | 155,297 | 139,511 | 286,068 | 254,866 |
| Loss from operations | (110,552) | (127,056) | (220,577) | (233,685) |
| Interest income, net | 9,730 | 14,513 | 20,525 | 30,600 |
| Other income, net | 119 | 523 | 238 | 1,776 |
| Net loss | $(100,703) | $(112,020) | $(199,814) | $(201,309) |
| Net loss per share - basic and diluted | $(1.69) | $(1.93) | $(3.38) | $(3.49) |
| Weighted-average number of common shares used in computing net loss per share – basic and diluted | 59,488,871 | 57,932,576 | 59,137,508 | 57,697,193 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's EPS (basic)?
- Agios Pharmaceuticals (AGIO) reported EPS (basic) of -$1.69 in Q2 2026.
- How has Agios Pharmaceuticals's EPS (basic) changed year-over-year?
- Agios Pharmaceuticals's EPS (basic) increased by 12.4% year-over-year, from -$1.93 to -$1.69.
- What is the long-term trend for Agios Pharmaceuticals's EPS (basic)?
- Over 2 years (2021 to 2025), Agios Pharmaceuticals's EPS (basic) has grown at a -43.5% compound annual growth rate (CAGR), from $22.24 to -$7.11.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Agios Pharmaceuticals's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude